CYP19A1 and breast carcinoma: Medication to reduce the risk of breast cancer: The USPSTF recommends that physicians offer to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women at increased risk of breast cancer and low risk of adverse effects from the medication (grade B) [58].